KOLBRAFNO owner Contact Information online
from Glaxo Group Limited
KOLBRAFNO
US serial number:85166066
Application filling date:Nov. 01, 2010
Register:Principal
Mark type:Trademark
Status:Abandoned because no Statement of Use or Extension Request timely filed after Notice of Allowance was issued. To view all documents in this file, click on the Trademark Document Retrieval link at the top of this page.
Status date:Aug. 18, 2014
Publication date:May 17, 2011
Abandoned date:Aug. 18, 2014
Standard character claim:Yes. The mark consists of standard characters without claim to any particular font style, size, or color.
Mark drawing type:4 - STANDARD CHARACTER MARK
Foreign foreign registration number:2561852
Foreign foreign registration date:Oct. 11, 2010
Foreign foreign application registration country:UNITED KINGDOM
Foreign foreign expiration date:Oct. 11, 2020
Goods and services:For: Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive
Current owner owner name:Glaxo Group Limited
Current owner owner address:980 Great West Road
Brentford, Middlesex
UNITED KINGDOM
TW89GS
Current owner legal entity type:CORPORATION
Current owner state or country:UNITED KINGDOM
Attorney name:Diane Fry Maginnis
Attorney email:trademarks@gsk.com
Attorney docket number:APP/KOLBRAFN
Attorney email authorized:Yes
Correspondent name address:DIANE FRY MAGINNIS
GLAXOSMITHKLINE
5 MOORE DR
RESEARCH TRIANGLE PARK,
NORTH CAROLINA
UNITED STATES
27709-0143
Correspondent phone:919-483-9618
Correspondent email:trademarks@gsk.com
Correspondent fax:704-625-9190
Correspondent email authorized:Yes
Trademark staff tm attorney:MCMORROW, RONALD G
Trademark staff law office assigned KOLBRAFNO:LAW OFFICE 118
Latest trademarks
Popular owners
Glaxo Group Limited (178) Novartis AG (130) JOHNSON & JOHNSON (124) Millennium Pharmaceuticals, Inc. (54) Eli Lilly and Company (51) Windmill Health Products, LLC (46) Bayer Aktiengesellschaft (45) SANOFI (41) Wyeth LLC (41) Pfizer Inc. (39) Bristol-Myers Squibb Company (34) Forest Laboratories, Inc. (34) S. C. Johnson & Son, Inc. (31) Vital Health Pharmaceuticals, Inc. (31) Primary Investments Group Limited (28) MERCK SHARP & DOHME CORP. (27) Futurebiotics, LLC (26) MONSTER ENERGY COMPANY (20) Scott Riddell (17) Biocept, Inc. (16)Popular publication dates
May 17, 2011 Mar. 08, 2011 Mar. 15, 2011 Mar. 22, 2011 Nov. 16, 2010 Apr. 19, 2011 Mar. 29, 2011 Apr. 12, 2011 Oct. 19, 2010 Oct. 26, 2010 Apr. 26, 2011 Feb. 15, 2011 Oct. 05, 2010 Oct. 12, 2010 Jan. 25, 2011 Sep. 21, 2010 Jan. 11, 2011 Feb. 22, 2011 Nov. 23, 2010 Sep. 28, 2010Similar brands
